Rosuvastatin Drug Profile

What is Rosuvastatin?

Rosuvastatin is a prescription medication belonging to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease in adults. Rosuvastatin is considered one of the most potent statins available for treating high cholesterol and preventing heart attacks and strokes.

Uses

Rosuvastatin is approved for several cardiovascular conditions:

• High cholesterol (hyperlipidemia): Reduces LDL (“bad”) cholesterol and total cholesterol levels while modestly increasing HDL (“good”) cholesterol
• Primary prevention of cardiovascular disease: Prevents first heart attacks and strokes in people with risk factors like diabetes, high blood pressure, or family history
• Secondary prevention: Reduces risk of repeat cardiovascular events in patients who have already experienced heart attacks, strokes, or other cardiovascular complications
• Mixed dyslipidemia: Treats multiple lipid abnormalities including elevated triglycerides and low HDL cholesterol
• Familial hypercholesterolemia: Manages inherited forms of high cholesterol in both adults and children over 8 years old

How it works

Rosuvastatin works by blocking HMG-CoA reductase, an enzyme that plays a crucial role in cholesterol production in the liver. By inhibiting this enzyme, the medication reduces the liver’s ability to manufacture cholesterol, forcing it to remove more cholesterol from the bloodstream. This mechanism effectively lowers blood cholesterol levels and may also have anti-inflammatory effects that benefit cardiovascular health.

Side effects

Common side effects:

Submit Your Paper

• Headache
• Muscle pain or weakness
• Nausea
• Stomach pain or discomfort
• Constipation
• Dizziness
• Fatigue or weakness
• Memory problems or confusion

Serious side effects requiring immediate medical attention:

• Severe muscle pain, tenderness, or weakness (possible rhabdomyolysis)
• Dark-colored urine or decreased urination
• Yellowing of skin or eyes (jaundice)
• Severe abdominal pain
• Unexplained fatigue or fever

Warnings and precautions

• Liver disease: Patients with active liver disease or persistently elevated liver enzymes should not use rosuvastatin. Regular liver function monitoring may be recommended.
• Kidney impairment: Dose adjustments are necessary for patients with severe kidney disease, and the medication should be used cautiously in those with kidney problems.
• Pregnancy and breastfeeding: Rosuvastatin is contraindicated during pregnancy and breastfeeding as it may harm the developing fetus or nursing infant.
• Muscle disorders: Patients with a history of muscle problems or those taking certain other medications may have increased risk of serious muscle complications.
• Diabetes risk: Statin therapy may slightly increase blood sugar levels and the risk of developing type 2 diabetes, particularly in predisposed individuals.

Interactions

• Cyclosporine: Significantly increases rosuvastatin levels, requiring dose reduction or alternative therapy
• Gemfibrozil: Increases risk of muscle damage when combined with rosuvastatin
• Warfarin: May enhance blood-thinning effects, requiring closer monitoring of clotting times
• Antacids containing aluminum or magnesium: Can reduce rosuvastatin absorption when taken simultaneously
• Certain HIV protease inhibitors: May increase rosuvastatin levels and toxicity risk
• Fenofibrate: Combination may increase risk of muscle problems
• Niacin (high doses): May increase risk of muscle complications when used together
• Red yeast rice supplements: Contains natural statins and may increase risk of side effects

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages range from 5 mg to 40 mg taken once daily, usually in the evening. Most patients start with 10-20 mg daily, with adjustments made based on cholesterol response and tolerability. The maximum recommended dose is 40 mg daily, which is reserved for patients who have not achieved adequate cholesterol reduction with lower doses. Dosage should always be individualized and determined by a healthcare provider based on the patient’s specific condition, risk factors, and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).